INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
SG

Salvia Investment GmbH

10% OwnerCIK 0002162499

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells1 / 0
Max Insider Score43
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
3.14M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Bambusa Therapeutics, Inc.10% Owner · Nov 2, 2026
21
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C
—
4.77M sh
Nov 2, 2026
Nov 2, 2026
traded Nov 2, 2026
+0d
SEC FORM 4

Evidence

43
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Open-market purchase
BUY$6.00M
375.0K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
1.47M sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence

9
SG
Salvia Investment GmbH10% Owner
BBTXBambusa Therapeutics, Inc.
Derivative conversion
C—
160.9K sh
Nov 2, 2026Nov 2, 2026
traded Nov 2, 2026
+0dSEC FORM 4

Evidence